Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report)’s stock price was down 0.7% during mid-day trading on Tuesday . The company traded as low as $0.35 and last traded at $0.36. Approximately 462,198 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 28,576,861 shares. The stock had previously closed at $0.36.
Eterna Therapeutics Stock Down 0.7 %
The company has a market cap of $1.94 million, a price-to-earnings ratio of -0.04 and a beta of 4.29. The business has a 50-day simple moving average of $0.36 and a two-hundred day simple moving average of $0.99.
Eterna Therapeutics (NASDAQ:ERNA – Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($4.92) EPS for the quarter. The company had revenue of $0.49 million for the quarter.
Eterna Therapeutics Company Profile
Eterna Therapeutics Inc, a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited.
Recommended Stories
- Five stocks we like better than Eterna Therapeutics
- How to Invest in Small Cap Stocks
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Earnings Per Share Calculator: How to Calculate EPS
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Options Trading – Understanding Strike Price
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Eterna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eterna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
